Rapamycin, proliferation and geroconversion to senescence
Year: 2018
Type: editorial
Abstract: Rapamycin inhibits cell proliferation, yet preserves (re)-proliferative potential (RPP). RPP is a potential of quiescent cells that is lost in senescent cells. mTOR drives conversion from quiescence to senescence (geroconversion). By suppressing geroconversion, rapamycin preserves RPP. Geroconversion is characterized by proliferation-like levels of phospho-S6K/S6/4E-BP1 in nonproliferating cells arrested by p16 and/or p21. mTOR-driven geroconversion is associated with cellular hyperfunction, which in turn leads to organismal aging manifested by age-related diseases.
Source: Cell Cycle
Author: Mikhail V. Blagosklonny
Institution: Roswell Park Comprehensive Cancer Center
Language: English
Subfield: Aging
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W2903820573
